PROSPECTIVE RANDOMISED TRIAL OF TAMOXIFEN VERSUS SURGERY IN ELDERLY PATIENTS WITH BREAST CANCER
- 1 March 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8587), 679-681
- https://doi.org/10.1016/s0140-6736(88)91478-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- PREDICTION OF ENDOCRINE RESPONSE IN BREAST CANCER BY IMMUNOCYTOCHEMICAL DETECTION OF OESTROGEN RECEPTOR IN FINE-NEEDLE ASPIRATESThe Lancet, 1987
- Tamoxifen as sole therapy for localised breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management.BMJ, 1985
- CONTROLLED TRIAL OF TAMOXIFEN AS SINGLE ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST-CANCER - ANALYSIS AT 6 YEARS1985
- Treatment of early localized breast cancer in elderly patients by TamoxifenThe British Journal of Radiology, 1982
- Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.BMJ, 1982
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977